• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Non-O Blood Groups Associated with Higher Coronary Heart Disease Risk

August 24, 2012

A recent study and analysis by Dr. Lu Qi and colleagues from the Harvard University found that even after controlling for background cardiovascular risk, individuals with non-O blood groups were more likely to develop coronary heart disease (CHD) than those with blood type O. The analysis, published in Arteriosclerosis, Thrombosis, and Vascular Biology, evaluated longitudinal patient-level data from the Nurses’ Health Study, which included more than 62,000 women tracked over 26 years, and the Health Professionals Follow-up Study, which followed more than 27,000 men over 24 years. The data showed that among ABO blood groups, the AB group was associated with highest CHD risk (Odds Ratio = 1.23), and that Rh type was not associated with CHD risk.  Results from these cohorts were confirmed by a meta-analysis conducted by the authors, using seven recent studies on the relationship of ABO blood group and CHD risk. The mechanisms underlying the association of blood group and CHD are not fully clear, but may be driven by elevated levels of the factor VIII-von Willebrand factor complex among non-O individuals. 

Reference:

1. He M, Wolpin B, Rexrode K, Manson JE, Rimm E, Hu FB, Qi L. ABO Blood Group and Risk of Coronary Heart Disease in Two Prospective Cohort Studies. Arterioscler Thromb Vasc Biol 2012;32: 2314-20.

Filed Under

  • News
  • Serology/Genotyping

Recommended

  • Prophylactic Platelet Transfusions are Not Superior to Supportive Care for Dengue Patients with Thrombocytopenia

  • Antibodies to Amustaline/Glutathione Pathogen Reduced RBCs

  • Cytomegalovirus (CMV) Seronegative and Leukoreduced Blood Transfusion Prevents Transmission of CMV in Very Low-Birth-Weight Infants

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Machine Learning Model for Estimating Perioperative Transfusion Risks

  • Blood Transfusion Strategies for Major Trauma

  • Storage Duration Affects Hematological and Metabolic Parameters in Patients with Sickle Cell Disease

  • Syphilis Infections Among US Blood Donors

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley